Clinical Trials Browser

Interventional × Restraint, Physical × Gastrointestinal × Clear all

Gastrointestinal Diseases, Gastrointestinal Neoplasms

NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

NCT03714555 2023-10-18

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

Phase 2 Terminated

1 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02900677 2016-09-14

Developing Prehabilitation Program in Patients With Operable Pancreatic Cancer Perioperatively and Following Surgery

Phase NA Unknown

168 enrolled

Gastrointestinal

Fatigue, Pancreatic Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Phase 2 Unknown

110 enrolled

Gastrointestinal

Rectal Neoplasms

Clinical Trials

Advancing Nursing Practices in Hospital Oncology Care

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

Developing Prehabilitation Program in Patients With Operable Pancreatic Cancer Perioperatively and Following Surgery

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).